China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE: 000999)
China
· Delayed Price · Currency is CNY 44.74
-0.66 (-1.45%)
Sep 9, 2024, 1:47 PM CST
China Resources Sanjiu Medical & Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 25,351 | 23,837 | 17,411 | 14,825 | 13,093 | 14,320 | Upgrade
|
| Other Revenue | 347.68 | 901.47 | 667.99 | 719.33 | 544.28 | 473.49 | Upgrade
|
| Revenue | 25,699 | 24,739 | 18,079 | 15,544 | 13,637 | 14,794 | Upgrade
|
| Revenue Growth (YoY) | 12.59% | 36.83% | 16.31% | 13.98% | -7.82% | 10.17% | Upgrade
|
| Cost of Revenue | 11,976 | 11,726 | 8,354 | 6,561 | 5,143 | 4,905 | Upgrade
|
| Gross Profit | 13,723 | 13,013 | 9,725 | 8,984 | 8,494 | 9,889 | Upgrade
|
| Selling, General & Admin | 8,544 | 8,489 | 6,135 | 5,992 | 5,947 | 7,540 | Upgrade
|
| Research & Development | 745.75 | 714.5 | 593.94 | 560.2 | 459.84 | 441.88 | Upgrade
|
| Other Operating Expenses | 172.89 | 262.72 | 207.05 | 204.39 | 175.49 | 206.11 | Upgrade
|
| Operating Expenses | 9,467 | 9,521 | 6,942 | 6,770 | 6,602 | 8,201 | Upgrade
|
| Operating Income | 4,256 | 3,492 | 2,784 | 2,214 | 1,892 | 1,688 | Upgrade
|
| Interest Expense | -53.74 | -80.78 | -21.23 | -14.18 | -5.09 | -4.41 | Upgrade
|
| Interest & Investment Income | 93.51 | 125.1 | 118.11 | 101.08 | 156.22 | 871.91 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.17 | 2.5 | -56.25 | -12.89 | -9.68 | -23.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -39.47 | -17.44 | -4.11 | -1.11 | -21.91 | -19.68 | Upgrade
|
| EBT Excluding Unusual Items | 4,256 | 3,521 | 2,820 | 2,287 | 2,012 | 2,513 | Upgrade
|
| Impairment of Goodwill | - | - | -65.51 | -44.24 | -174.95 | -191.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | -22.99 | -28.63 | 2.58 | 5.04 | 6.87 | 0.61 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1 | 0.81 | 2.28 | 0.85 | -2.69 | -1.82 | Upgrade
|
| Asset Writedown | -48.66 | -31.48 | -34.3 | -8.1 | -7.95 | -0.32 | Upgrade
|
| Other Unusual Items | 235.01 | 292.43 | 237.69 | 202.96 | 225.89 | 233.66 | Upgrade
|
| Pretax Income | 4,418 | 3,754 | 2,963 | 2,444 | 2,059 | 2,555 | Upgrade
|
| Income Tax Expense | 727.51 | 580.97 | 466.43 | 345.41 | 441.89 | 429.55 | Upgrade
|
| Earnings From Continuing Operations | 3,691 | 3,173 | 2,497 | 2,099 | 1,618 | 2,125 | Upgrade
|
| Minority Interest in Earnings | -316.51 | -320.55 | -48.21 | -43.49 | -20.04 | -26.59 | Upgrade
|
| Net Income | 3,374 | 2,853 | 2,449 | 2,055 | 1,597 | 2,099 | Upgrade
|
| Net Income to Common | 3,374 | 2,853 | 2,449 | 2,055 | 1,597 | 2,099 | Upgrade
|
| Net Income Growth | 16.64% | 16.50% | 19.16% | 28.65% | -23.89% | 46.56% | Upgrade
|
| Shares Outstanding (Basic) | 1,281 | 1,279 | 1,284 | 1,272 | 1,274 | 1,275 | Upgrade
|
| Shares Outstanding (Diluted) | 1,281 | 1,279 | 1,284 | 1,272 | 1,274 | 1,275 | Upgrade
|
| Shares Change (YoY) | -0.24% | -0.37% | 0.90% | -0.15% | -0.07% | -0.01% | Upgrade
|
| EPS (Basic) | 2.63 | 2.23 | 1.91 | 1.62 | 1.25 | 1.65 | Upgrade
|
| EPS (Diluted) | 2.63 | 2.23 | 1.91 | 1.62 | 1.25 | 1.65 | Upgrade
|
| EPS Growth | 16.92% | 16.94% | 18.09% | 28.84% | -23.84% | 46.58% | Upgrade
|
| Free Cash Flow | 3,995 | 3,335 | 2,055 | 1,012 | 1,602 | 1,411 | Upgrade
|
| Free Cash Flow Per Share | 3.12 | 2.61 | 1.60 | 0.80 | 1.26 | 1.11 | Upgrade
|
| Dividend Per Share | 1.154 | 1.154 | 0.769 | 0.656 | 0.385 | 0.331 | Upgrade
|
| Dividend Growth | 50.00% | 50.00% | 17.26% | 70.57% | 16.26% | 10.27% | Upgrade
|
| Gross Margin | 53.40% | 52.60% | 53.79% | 57.79% | 62.28% | 66.85% | Upgrade
|
| Operating Margin | 16.56% | 14.12% | 15.40% | 14.24% | 13.87% | 11.41% | Upgrade
|
| Profit Margin | 13.13% | 11.53% | 13.54% | 13.22% | 11.71% | 14.19% | Upgrade
|
| Free Cash Flow Margin | 15.54% | 13.48% | 11.37% | 6.51% | 11.75% | 9.54% | Upgrade
|
| EBITDA | 4,994 | 4,178 | 3,251 | 2,643 | 2,282 | 2,023 | Upgrade
|
| EBITDA Margin | 19.43% | 16.89% | 17.98% | 17.00% | 16.73% | 13.68% | Upgrade
|
| D&A For EBITDA | 738.11 | 685.71 | 467.17 | 429.17 | 390.19 | 335.18 | Upgrade
|
| EBIT | 4,256 | 3,492 | 2,784 | 2,214 | 1,892 | 1,688 | Upgrade
|
| EBIT Margin | 16.56% | 14.12% | 15.40% | 14.24% | 13.87% | 11.41% | Upgrade
|
| Effective Tax Rate | 16.47% | 15.47% | 15.74% | 14.13% | 21.46% | 16.81% | Upgrade
|
| Revenue as Reported | 11,593 | 24,739 | 18,079 | 15,544 | 13,637 | 14,794 | Upgrade
|
| Advertising Expenses | - | 660.33 | 543.92 | 578.72 | 446.69 | 497.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.